Developer docs
API playgroundTry for free, no card

Search company profiles

datma

Full company profile

uuid0000dj2

Namestring
datma
Legal namestring
datma, Inc.
Websiteurl
datma.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

datma is a private Beaverton, Oregon-based healthcare data technology company (founded 2016, formerly Omics Data Automation) that operates a federated real-world data platform enabling health systems, molecular laboratories, and pharmaceutical companies to collaborate on multimodal healthcare data without moving identifiable patient information outside custodian infrastructure. Its product suite centers on datma.FED, a two-sided marketplace launched October 2024 that matches data custodians with pharma data consumers under a shared-upside revenue model; datma.BASE, a data management layer with specialized columnar stores for omics (OmicsDS), imaging (ImageDS/PathDS), and EHR data (EhrDS) connected via FHIR, DICOM, and VCF integrations; and datma.360, a visualization and clinical decision support layer that consolidates omics, clinical, and imaging data into single patient profiles with built-in trial matching, tumor board scheduling, and prior authorization automation.

The platform supports multimodal AI workloads across its data assets: federated causal modeling (datma.WHY), computer vision for digital pathology (used by UPenn researchers to predict heart transplant rejection), NLP over clinical notes and reports, generative AI for patient journey mapping in NSCLC, and knowledge retrieval against OncoKB and ClinicalTrials.gov. The federated network had surpassed 1 million patient lives with multi-omic and pathology coverage as of March 2025, anchored by relationships with Providence Cancer Institute, UCSF Hope Consortium, UPenn, a multi-state hospital network, Novartis, the Broad Institute, UCLA, and the GOAL Consortium. datma also holds US Patent 12,094,105 B2 on automated pathology image labeling, co-developed with Providence Health & Services.

datma monetizes through three streams: marketplace commissions and shared-upside economics on datma.FED, enterprise subscriptions for datma.BASE and datma.360, and professional services for evidence-generation studies that connect pharma sponsors with health system investigators. Distribution is a hybrid of direct enterprise sales and a product-led free tier via the Federated Biomarker Explorer, which lets pharma teams assess biomarker coverage across the network before committing to procurement. The company is privately held, has 11-50 employees, and has raised approximately $21.2M in disclosed funding led by Transformation Capital and Generator Ventures, with no disclosed round since June 2022.

Short descriptiontext

datma is a private healthcare technology company that operates a federated real-world data platform connecting health systems, molecular labs, and pharmaceutical companies through privacy-preserving multimodal data collaboration, anchored by datma.FED, datma.BASE, and datma.360.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeaverton, United States
HQ citystring
Beaverton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
federated real-world data, healthcare data platform, biomedical informatics, multimodal data integration, clinical evidence generation
Industry6 codes
PRIMARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAL
Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAA
Healthcare Data Lakes, Lakehouses & Cloud Warehouses
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAI
FHIR/HL7 Data Repositories & Canonical Data Models
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAIAK
De-identification, Tokenization & Privacy-Preserving Data Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
NAICS code5 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
  • Computer Systems Design and Related Services54151
SIC code3 codes
  • Services-Computer Processing & Data Preparation7374
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Computer Integrated Systems Design7373
Product category
Healthcare Real-World Data / Federated Data Platform
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Data Marketplace Commission
TypeMarketplace Commission
Description

datma.FED operates as a two-sided marketplace where data custodians (health systems, labs) provide data to pharmaceutical companies and research organizations. Revenue is generated through a 'shared-upside' model where custodians earn revenue each time a new data consumer joins the network, and revenue scales as the network expands.

datma.com
2Platform Subscription/Licensing
TypeSubscription Recurring
Description

datma.BASE and datma.360 are offered as subscription-based platforms for health systems and labs to manage, harmonize, and visualize their healthcare data. Organizations pay for access to data management, integration, and visualization capabilities.

datma.com
3Evidence Generation Studies
TypeProfessional Services
Description

datma facilitates sponsored research collaborations between health systems and pharmaceutical companies, managing study setup, approvals, investigator onboarding, and data execution. Health systems receive funding from pharmaceutical partners for participating in evidence generation projects.

datma.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details2 tiers
1Free tier with limited biomarker exploration capabilities
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free access to biomarker explorer application to explore biomarker prevalence in datma.FED data. Access limited to evaluating data utility, not shareable with external entities. Subscription term of 120 days from activation date or until user procures paid access.

datma.com
2Enterprise/paid tier for full datma.FED access
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for pharmaceutical companies accessing full federated query capabilities and for health systems/labs monetizing their data. Revenue model based on shared-upside with data custodians earning as network grows.

datma.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1datma.BASE
Description

A scalable data management platform that provides a solution for ingesting, aggregating, and harmonizing multimodal healthcare data, eliminating data silos and facilitating efficient analysis.

datma.com
+3 more records
Core offering1 text field

datma develops a cloud-based federated real-world data platform for ingesting, harmonizing, analyzing, and federating large multimodal healthcare datasets including omics, digital pathology, imaging, and EHR data. Its flagship datma.FED acts as a two-sided privacy-preserving marketplace that connects health systems and molecular/reference labs (as data custodians) with pharmaceutical companies and research organizations (as data consumers), enabling federated queries and analytics while keeping identifiable patient data inside the custodian's infrastructure. Supporting products include datma.BASE for data management and harmonization, datma.360 for visualization and clinical decision support, the Federated Biomarker Explorer for free biomarker coverage assessment, and datma.WHY for federated causal modeling.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Achieved up to 50 providers attending biweekly synchronous tumor board sessions across geographic areas including underserved and remote regions
+3 more records
Product overview1 text field

datma offers a platform technology and associated software for ingesting, aggregating, harmonizing, and visualizing heterogeneous multimodal healthcare data. The product architecture consists of a core data management platform (datma.BASE) with specialized data stores (OmicsDS, ImageDS/PathDS, EhrDS), augmented by visualization and clinical decision support tools (datma.360), and a federated data marketplace (datma.FED) that enables secure collaboration without centralizing sensitive data. Additional modules include the Federated Biomarker Explorer for data feasibility assessment and the datma.WHY causal modeling framework.

Product and service4 records
1datma.FED
CategoryFederated real-world data marketplace
Description

A federated real-world data marketplace that connects health systems and molecular/reference labs with pharmaceutical companies and researchers through a secure, privacy-preserving federated model. Enables federated queries and analyses over multimodal data (omics, pathology, imaging, EHR) while identifiable patient-level data never leaves the custodian's infrastructure; offers shared-upside revenue to data custodians and is offered via subscription and a free Federated Biomarker Explorer entry point.

2datma.BASE
CategoryBiomedical data management platform
Description

A scalable biomedical information management platform providing ingestion, aggregation, harmonization, and storage of multimodal healthcare data via proprietary columnar data stores (OmicsDS, ImageDS/PathDS, EhrDS) and a RESTful API with native FHIR, DICOM, and VCF support and JupyterLab integration. Sold to health systems, research institutions, and pharmaceutical customers who need to manage and harmonize their own multimodal data.

3datma.360
CategoryClinical visualization and decision support
Description

An advanced visualization platform that augments EHR systems by consolidating omics, clinical, and imaging data into single comprehensive patient profiles, with clinical trial matching against ClinicalTrials.gov and OncoKB, tumor board scheduling with Microsoft Teams integration, prior authorization automation, cohort discovery, and outcome tracking.

4Federated Biomarker Explorer
CategoryBiomarker feasibility assessment tool
Description

A free self-serve tool for pharmaceutical teams that checks biomarker coverage and prevalence across datma's federated real-world data network without procurement, IT, or contracts, with a separate health systems variant that provides visibility into data demand without data sharing.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-22
Description

Exploratory collaboration to evaluate how datma.FED could support Rhythm's cancer risk prediction technology development. Aims to assess contribution of longitudinal, de-identified clinical data to support clinical utility and health economic modelling of Rhythm's geneType™ risk assessment portfolio, potentially enhancing commercialization and clinical validation of genomic-integrated cancer diagnostics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-18
Description

datma joined GOAL Consortium as Key Industry Supporter to advance innovation in academic genomics and precision medicine. The consortium represents academic genomics institutions working collaboratively on precision medicine research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative development of patent-protected pathology data labeling system (US12094105B2). Providence is a not-for-profit health system serving the Western U.S. datma's technology was developed in partnership with Providence to address critical challenges in healthcare data sharing.

Strategic tierStrategicTypeOthers
Description

Pharmaceutical collaboration listed under industry partnerships on pharma solutions page, indicating data collaboration for evidence generation and research purposes.

5The Broad Institute
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic research institution partnership listed as industry collaborator for advancing genomic research and precision medicine through federated data analysis.

datma.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration in precision medicine and genomic data analysis through federated infrastructure.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pediatric oncology research collaboration partner supporting childhood cancer research through federated data analysis capabilities.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Health system partnership for federated data collaboration supporting evidence generation and clinical research initiatives.

9UCSF Hope Consortium
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Research collaboration with UCSF's Hope Consortium supporting studies on causes of premature birth using datma.BASE platform for managing multimodal data including surveys, social determinants, Fitbits, clinical charts, and biospecimen analyses.

datma.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest global provider of real-world data, advanced analytics, and technology solutions for life sciences. A dominant incumbent with which datma competes for pharma RWD budgets.

TypeBroad incumbent
Description

Oncology-focused real-world data and EHR company (Roche subsidiary) serving biopharma and providers. A direct competitor in oncology RWD with substantially larger datasets and pharma relationships.

TypeDirect peer
Description

Operates a global federated health research network connecting healthcare organizations with biopharma for clinical research and real-world evidence, the most direct analogue to datma.FED's marketplace model.

TypeDirect peer
Description

Real-world evidence and AI solutions for oncology and life sciences, operating a federated RWD network serving pharma research. Highly comparable business model and target customer base.

TypeDirect peer
Description

Real-world evidence platform for oncology connecting health systems with life sciences companies. Comparable two-sided RWD business model with focus on precision medicine.

6Tempus
TypeBroad incumbent
Description

Multi-modal health data platform combining omics, imaging, and clinical data with AI applications, serving pharma, providers, and patients. A larger, well-capitalized incumbent with overlapping multimodal data capabilities.

TypeDirect peer
Description

Federated genomics and biomedical data platform enabling secure, cloud-based analysis across distributed datasets. Direct peer in the federated biomedical data space with comparable technology approach.

TypeBroad incumbent
Description

Healthcare data and analytics platform serving health systems with data warehousing, integration, and population health. Overlapping platform technology for healthcare data management at scale.

TypeBroad incumbent
Description

Data integration and analytics platform with growing healthcare and life sciences presence (e.g., Foundry for biomedicine). Provides competing data infrastructure for pharma and provider organizations.

TypeEmerging player
Description

Genomic and clinical data management platform operating a federated data network for pharma research and precision medicine. Comparable in scope though smaller in scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

datma

Healthcare Real-World Data / Federated Data Platformdatma.com

datma is a private healthcare technology company that operates a federated real-world data platform connecting health systems, molecular labs, and pharmaceutical companies through privacy-preserving multimodal data collaboration, anchored by datma.FED, datma.BASE, and datma.360.

What datma does

datma is a private Beaverton, Oregon-based healthcare data technology company (founded 2016, formerly Omics Data Automation) that operates a federated real-world data platform enabling health systems, molecular laboratories, and pharmaceutical companies to collaborate on multimodal healthcare data without moving identifiable patient information outside custodian infrastructure. Its product suite centers on datma.FED, a two-sided marketplace launched October 2024 that matches data custodians with pharma data consumers under a shared-upside revenue model; datma.BASE, a data management layer with specialized columnar stores for omics (OmicsDS), imaging (ImageDS/PathDS), and EHR data (EhrDS) connected via FHIR, DICOM, and VCF integrations; and datma.360, a visualization and clinical decision support layer that consolidates omics, clinical, and imaging data into single patient profiles with built-in trial matching, tumor board scheduling, and prior authorization automation.

The platform supports multimodal AI workloads across its data assets: federated causal modeling (datma.WHY), computer vision for digital pathology (used by UPenn researchers to predict heart transplant rejection), NLP over clinical notes and reports, generative AI for patient journey mapping in NSCLC, and knowledge retrieval against OncoKB and ClinicalTrials.gov. The federated network had surpassed 1 million patient lives with multi-omic and pathology coverage as of March 2025, anchored by relationships with Providence Cancer Institute, UCSF Hope Consortium, UPenn, a multi-state hospital network, Novartis, the Broad Institute, UCLA, and the GOAL Consortium. datma also holds US Patent 12,094,105 B2 on automated pathology image labeling, co-developed with Providence Health & Services.

datma monetizes through three streams: marketplace commissions and shared-upside economics on datma.FED, enterprise subscriptions for datma.BASE and datma.360, and professional services for evidence-generation studies that connect pharma sponsors with health system investigators. Distribution is a hybrid of direct enterprise sales and a product-led free tier via the Federated Biomarker Explorer, which lets pharma teams assess biomarker coverage across the network before committing to procurement. The company is privately held, has 11-50 employees, and has raised approximately $21.2M in disclosed funding led by Transformation Capital and Generator Ventures, with no disclosed round since June 2022.

datma firmographics

Firmographics
Name
datma
Legal name
datma, Inc.
Website
https://datma.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
datma is a private healthcare technology company that operates a federated real-world data platform connecting health systems, molecular labs, and pharmaceutical companies through privacy-preserving multimodal data collaboration, anchored by datma.FED, datma.BASE, and datma.360.
Ownership category
akta.pro rank

datma industry classification

Industry
Product category
Healthcare Real-World Data / Federated Data Platform
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Computer Systems Design and Related Services (54151)
SIC
Services-Computer Processing & Data Preparation (7374), Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAL
Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAA
Healthcare Data Lakes, Lakehouses & Cloud Warehouses
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAI
FHIR/HL7 Data Repositories & Canonical Data Models
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAIAK
De-identification, Tokenization & Privacy-Preserving Data Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance

Keywords

  • Federated real-world data
  • Healthcare data platform
  • Biomedical informatics
  • Multimodal data integration
  • Clinical evidence generation

Where datma is headquartered

Location

Headquarters

HQ city
Beaverton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

datma business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Data Marketplace Commission: datma.FED operates as a two-sided marketplace where data custodians (health systems, labs) provide data to pharmaceutical companies and research organizations. Revenue is generated through a 'shared-upside' model where custodians earn revenue each time a new data consumer joins the network, and revenue scales as the network expands.
  2. Platform Subscription/Licensing: datma.BASE and datma.360 are offered as subscription-based platforms for health systems and labs to manage, harmonize, and visualize their healthcare data. Organizations pay for access to data management, integration, and visualization capabilities.
  3. Evidence Generation Studies: datma facilitates sponsored research collaborations between health systems and pharmaceutical companies, managing study setup, approvals, investigator onboarding, and data execution. Health systems receive funding from pharmaceutical partners for participating in evidence generation projects.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree tier with limited biomarker exploration capabilities
SubscriptionAnnualEnterprise/paid tier for full datma.FED access

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

datma product offering

Product offering

Core offering

datma develops a cloud-based federated real-world data platform for ingesting, harmonizing, analyzing, and federating large multimodal healthcare datasets including omics, digital pathology, imaging, and EHR data. Its flagship datma.FED acts as a two-sided privacy-preserving marketplace that connects health systems and molecular/reference labs (as data custodians) with pharmaceutical companies and research organizations (as data consumers), enabling federated queries and analytics while keeping identifiable patient data inside the custodian's infrastructure. Supporting products include datma.BASE for data management and harmonization, datma.360 for visualization and clinical decision support, the Federated Biomarker Explorer for free biomarker coverage assessment, and datma.WHY for federated causal modeling.

Product overview

datma offers a platform technology and associated software for ingesting, aggregating, harmonizing, and visualizing heterogeneous multimodal healthcare data. The product architecture consists of a core data management platform (datma.BASE) with specialized data stores (OmicsDS, ImageDS/PathDS, EhrDS), augmented by visualization and clinical decision support tools (datma.360), and a federated data marketplace (datma.FED) that enables secure collaboration without centralizing sensitive data. Additional modules include the Federated Biomarker Explorer for data feasibility assessment and the datma.WHY causal modeling framework.

Differentiator

Problem solved

Functional benefit

Brands

  • datma.BASE: A scalable data management platform that provides a solution for ingesting, aggregating, and harmonizing multimodal healthcare data, eliminating data silos and facilitating efficient analysis.
  • datma.360
  • datma.FED
  • Federated Biomarker Explorer

Products and services

  • datma.FED A federated real-world data marketplace that connects health systems and molecular/reference labs with pharmaceutical companies and researchers through a secure, privacy-preserving federated model. Enables federated queries and analyses over multimodal data (omics, pathology, imaging, EHR) while identifiable patient-level data never leaves the custodian's infrastructure; offers shared-upside revenue to data custodians and is offered via subscription and a free Federated Biomarker Explorer entry point.
  • datma.BASE A scalable biomedical information management platform providing ingestion, aggregation, harmonization, and storage of multimodal healthcare data via proprietary columnar data stores (OmicsDS, ImageDS/PathDS, EhrDS) and a RESTful API with native FHIR, DICOM, and VCF support and JupyterLab integration. Sold to health systems, research institutions, and pharmaceutical customers who need to manage and harmonize their own multimodal data.
  • datma.360 An advanced visualization platform that augments EHR systems by consolidating omics, clinical, and imaging data into single comprehensive patient profiles, with clinical trial matching against ClinicalTrials.gov and OncoKB, tumor board scheduling with Microsoft Teams integration, prior authorization automation, cohort discovery, and outcome tracking.
  • Federated Biomarker Explorer A free self-serve tool for pharmaceutical teams that checks biomarker coverage and prevalence across datma's federated real-world data network without procurement, IT, or contracts, with a separate health systems variant that provides visibility into data demand without data sharing.

Quantifiable outcome

  • Achieved up to 50 providers attending biweekly synchronous tumor board sessions across geographic areas including underserved and remote regions
  • +3 more outcomes

Companies that use datma

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

datma technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability11 records

Feature9 records

datma partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, strategic and minor.

  • Rhythm BiosciencescoreStrategic or Co-development Partner · 22 December 2025Exploratory collaboration to evaluate how datma.FED could support Rhythm's cancer risk prediction technology development. Aims to assess contribution of longitudinal, de-identified clinical data to support clinical utility and health economic modelling of Rhythm's geneType™ risk assessment portfolio, potentially enhancing commercialization and clinical validation of genomic-integrated cancer diagnostics.
  • GOAL ConsortiumcoreStrategic or Co-development Partner · 18 November 2024datma joined GOAL Consortium as Key Industry Supporter to advance innovation in academic genomics and precision medicine. The consortium represents academic genomics institutions working collaboratively on precision medicine research.
  • Providence Health & ServicescoreStrategic or Co-development PartnerCollaborative development of patent-protected pathology data labeling system (US12094105B2). Providence is a not-for-profit health system serving the Western U.S. datma's technology was developed in partnership with Providence to address critical challenges in healthcare data sharing.
  • NovartisstrategicOthersPharmaceutical collaboration listed under industry partnerships on pharma solutions page, indicating data collaboration for evidence generation and research purposes.
  • The Broad InstitutestrategicStrategic or Co-development PartnerAcademic research institution partnership listed as industry collaborator for advancing genomic research and precision medicine through federated data analysis.
  • UCLAstrategicStrategic or Co-development PartnerAcademic partnership for research collaboration in precision medicine and genomic data analysis through federated infrastructure.
  • Children's Cancer TherapyminorStrategic or Co-development PartnerPediatric oncology research collaboration partner supporting childhood cancer research through federated data analysis capabilities.
  • Providence HealthstrategicStrategic or Co-development PartnerHealth system partnership for federated data collaboration supporting evidence generation and clinical research initiatives.
  • UCSF Hope ConsortiumstrategicStrategic or Co-development PartnerResearch collaboration with UCSF's Hope Consortium supporting studies on causes of premature birth using datma.BASE platform for managing multimodal data including surveys, social determinants, Fitbits, clinical charts, and biospecimen analyses.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

datma competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Largest global provider of real-world data, advanced analytics, and technology solutions for life sciences. A dominant incumbent with which datma competes for pharma RWD budgets.
  • Flatiron Health: Oncology-focused real-world data and EHR company (Roche subsidiary) serving biopharma and providers. A direct competitor in oncology RWD with substantially larger datasets and pharma relationships.
  • Tempus: Multi-modal health data platform combining omics, imaging, and clinical data with AI applications, serving pharma, providers, and patients. A larger, well-capitalized incumbent with overlapping multimodal data capabilities.
  • Health Catalyst: Healthcare data and analytics platform serving health systems with data warehousing, integration, and population health. Overlapping platform technology for healthcare data management at scale.
  • Palantir Technologies: Data integration and analytics platform with growing healthcare and life sciences presence (e.g., Foundry for biomedicine). Provides competing data infrastructure for pharma and provider organizations.

Direct peers

  • TriNetX: Operates a global federated health research network connecting healthcare organizations with biopharma for clinical research and real-world evidence, the most direct analogue to datma.FED's marketplace model.
  • ConcertAI: Real-world evidence and AI solutions for oncology and life sciences, operating a federated RWD network serving pharma research. Highly comparable business model and target customer base.
  • Syapse: Real-world evidence platform for oncology connecting health systems with life sciences companies. Comparable two-sided RWD business model with focus on precision medicine.
  • Lifebit: Federated genomics and biomedical data platform enabling secure, cloud-based analysis across distributed datasets. Direct peer in the federated biomedical data space with comparable technology approach.

Emerging players

  • BC Platforms: Genomic and clinical data management platform operating a federated data network for pharma research and precision medicine. Comparable in scope though smaller in scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

datma social profiles

Digital presence

datma compliance and trust

Trust signal

Compliance3 records

datma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

datma leadership team

Management profile

Number of profiles

Profiles8 records

datma funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

datma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about datma

What does datma do?

datma develops a cloud-based federated real-world data platform for ingesting, harmonizing, analyzing, and federating large multimodal healthcare datasets including omics, digital pathology, imaging, and EHR data. Its flagship datma.FED acts as a two-sided privacy-preserving marketplace that connects health systems and molecular/reference labs (as data custodians) with pharmaceutical companies and research organizations (as data consumers), enabling federated queries and analytics while keeping identifiable patient data inside the custodian's infrastructure. Supporting products include datma.BASE for data management and harmonization, datma.360 for visualization and clinical decision support, the Federated Biomarker Explorer for free biomarker coverage assessment, and datma.WHY for federated causal modeling.

Is datma a public or private company?

datma is a private company. It is classified as venture growth investor backed and is currently operating.

When was datma founded?

datma was founded in 2016. It employs 11 to 50 people.

Where is datma based?

datma is headquartered in Beaverton, United States, in the North America region.

How does datma make money?

Three revenue lines are on record. Data Marketplace Commission is the primary driver. The others are platform Subscription/Licensing and evidence Generation Studies.

Who are datma's main competitors?

Broad incumbents on record are IQVIA, Flatiron Health, Tempus, Health Catalyst and Palantir Technologies. Direct peers are TriNetX, ConcertAI, Syapse and Lifebit. BC Platforms is listed as an emerging player.

Does datma have an API?

Yes. datma.BASE provides a RESTful API layer that provides access to data ingestion, extraction and compute. The API enables programmatic access to OmicsDS (genomics, transcriptomics, copy number variation, methylation data), ImageDS (pathology and medical imaging), and EhrDS (EHR/clinical data). APIs support REST endpoints for data ingestion in JSON, YAML, VCF, and other customizable formats. JupyterLab integration allows programmatic interaction. datma.FED provides API access for federated query execution across the network. Cohort specifications and analysis pipelines can be exchanged via API for federated analysis.

What industry is datma in?

datma's product category is Healthcare Real-World Data / Federated Data Platform. Its primary akta.pro industry code is HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation, with a secondary code of HLACAIAL, Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement). Its NAICS code is 51821 and its SIC code is 7374.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The AustralianRhythm Biosciences teams up with US-based datmaRhythm Biosciences (ASX:RHY) has entered an exploratory collaboration with US-based datma to evaluate how datma's federated data platform (datma.FED) could support the development and commercialization of Rhythm's genomic-integrated cancer risk prediction tools, including its geneType platform. The partnership aims to address data fragmentation and privacy barriers by enabling secure, privacy-preserving access to de-identified real-world clinical data across multiple healthcare organizations. datma CEO Noah Nasser and Rhythm Biosciences director of clinical affairs Dr Erika Spaeth provided statements on the collaboration's potential to advance genomic-integrated risk prediction for cancer diagnostics.PR Newswiredatma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Developmentdatma and Rhythm Biosciences announced an exploratory collaboration to evaluate how datma's federated real-world data platform, datma.FED, can support the development of Rhythm's genomic-integrated cancer risk prediction portfolio. The partnership aims to address data fragmentation and privacy constraints by enabling secure access to de-identified clinical data for evidence generation and health economic modeling. Subject to successful validation, the companies will discuss further commercial agreements.Streetinsiderdatma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Developmentdatma and Rhythm Biosciences Ltd have announced an exploratory collaboration to evaluate how datma.FED, a federated real-world data platform, could support and accelerate the commercialization of Rhythm's genomic-integrated cancer risk prediction portfolio, geneType™. The collaboration will assess how longitudinal, de-identified clinical data accessible via datma.FED may contribute to continued development of Rhythm's risk scoring technologies and support clinical utility evidence generation. Subject to successful validation, further partnership discussions will ensue, including potentially utilizing geneType™ technology within the datma.FED platform.PharmiWeb.comHealthcare Data Monetization Market Outlook 2025-2030 | Innovations Fueling Life Sciences ResearchThe global healthcare data monetization market is projected to expand at a compound annual growth rate of approximately 15% from 2025 to 2030, driven by rising demand for real-world evidence, widespread adoption of electronic health records, and the growth of AI-enabled analytics platforms. Notable recent developments include Atropos Health launching AI model-training capabilities on its federated network covering over 300 million patient records in December 2024, and datma, Inc. introducing datma.FED, a two-sided marketplace connecting data custodians with pharmaceutical companies and research organizations in October 2024. The market faces headwinds from data privacy concerns, interoperability challenges, and a lack of standardized data formats.PR Newswiredatma Unveils Federated Biomarker Explorer for Health Systems, Enabling Visibility Into Data Demand Without Data Sharing or Commitmentdatma has launched the Federated Biomarker Explorer for Health Systems, a tool allowing hospitals, cancer centers, and labs to validate pharmaceutical demand for their data before committing to partnerships. This initiative aims to eliminate uncertainty in data sharing arrangements by enabling health systems to see when their data is needed without sharing patient information or forming legal agreements. The tool is now available for early access registration.TechBullionUnlocking the Power of Molecular Lab Data: An Interview with Noah Nasser, CEO of datmadatma, a healthcare technology company, is enhancing the use of molecular lab data for research and patient outcomes through its federated data platform, datma.FED. The platform enables labs to monetize their de-identified data securely, help offset costs, and provide pharmaceutical companies with high-quality datasets for better decision-making. As datma scales globally, it continues to invest in AI-driven analytics and new solutions to foster data-driven healthcare advancements.Pulse 2.0datma: Interview With CEO Noah Nasser About Federated Real-World Data Platforms For Healthcaredatma CEO Noah Nasser outlined the company's strategy to expand its federated real-world data platform, datma.FED, by integrating new health systems and enhancing AI-enabled analytics tools in 2025. The company, which has raised approximately $18 million in venture funding, aims to connect data custodians with pharmaceutical clients to accelerate precision medicine research while maintaining data privacy.WbsmNew Bedford Plastic Rooster Kicks Off DATMA’s Sixth SeasonDATMA has launched its sixth season in New Bedford, featuring the 'Plastic Rooster,' a 15-foot sculpture by artist Bordalo II constructed from repurposed landfill waste. The organization is also offering educational workshops on environmental topics and wind energy in collaboration with partners like Vineyard Wind.Tech Company NewsAn Interview With Omics Data Automation CEO, Gans SrinivasaOmics Data Automation CEO Gans Srinivasa described the company's framework for aggregating medical data to enable precision medicine. The startup raised $747K and received an NSF SBIR Phase II grant, with software launching early 2019. The company aims to eliminate data silos and enable computation across medical data.